We observed increased collagen mRNA in donor (about 2.4-fold) and IPF patients (about 4.8-fold) fibroblasts after TGF-β1 treatment, when compared with control group (Fig. S7). The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.